Role of 5α-Reductase Inhibitors in Prostate Cancer Prevention and Treatment
Urology,  Clinical Article

Azzouni F et al. – The observation that males born with 5α–R 2 deficiency have never been reported to develop prostate cancer stimulated interest in development of 5 α–R inhibitors. Thus far, 2 5α–R inhibitors are approved for clinical use.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Nursing

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nursing Articles

Indexed Journals in Nursing: Journal of Advanced Nursing, Journal of Clinical Nursing, Nurse Education In Practicemore